Fanconi anemia is associated with a defect in the BRCA2 partner PALB2

Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification

Schouten, J. P. (2002) · Nucleic Acids Research · doi:10.1093/nar/gnf056 · Cited by 2,705 · see citing works

Alu repeats and human genomic diversity

Batzer, M., & Deininger, P. (2002) · Nature reviews genetics · doi:10.1038/nrg798 · Cited by 1,522 · see citing works

Biallelic Inactivation of <i>BRCA2</i> in Fanconi Anemia

Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002) · Science · doi:10.1126/science.1073834 · Cited by 1,149 · see citing works

Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2

Xia, B., Sheng, Q., Nakanishi, K., Ohashi, A., Wu, J., Christ, N., Liu, X., Jasin, M., Couch, F. J., & Livingston, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.022 · Cited by 861 · see citing works

The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J

Levitus, M., Waisfisz, Q., Godthelp, B. C., Vries, Y. D., Hussain, S., Wiegant, W. W., Elghalbzouri-Maghrani, E., Steltenpool, J., Rooimans, M. A., Pals, G., et al. (2005) · Nature Genetics · doi:10.1038/ng1625 · Cited by 432 · see citing works

Molecular pathogenesis of Fanconi anemia: recent progress

Taniguchi, T., & D’Andrea, A. D. (2006) · Blood · doi:10.1182/blood-2005-10-4240 · Cited by 387 · see citing works

Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2

Alter, B. P., Rosenberg, P. S., & Brody, L. C. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.043257 · Cited by 337 · see citing works

Spontaneous functional correction of homozygous Fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism

Waisfisz, Q., Morgan, N. V., Savino, M., de Winter, J. P., van Berkel, C. G. M., Hoatlin, M. E., Ianzano, L., Gibson, R. A., Arwert, F., Savoia, A., et al. (1999) · Nature Genetics · doi:10.1038/11956 · Cited by 208 · see citing works

The infant with a vascular tumor

Mueller, B. U., & Mulliken, J. B. (1999) · Seminars in Perinatology · doi:10.1016/s0146-0005(99)80041-x · Cited by 82 · see citing works

Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing

Bermejo, J. L., & Hemminki, K. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh474 · Cited by 77 · see citing works

Updated Classification of Hemangiomas and Other Vascular Anomalies

Chang, M. W. (2003) · Lymphatic Research and Biology · doi:10.1089/153968503322758067 · Cited by 76 · see citing works

Mechanism of Eukaryotic Homologous Recombination

Filippo, J. S., Sung, P., & Klein, H. L. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061306.125255 · Cited by 1,686 · see citing works

Homologous recombination in DNA repair and DNA damage tolerance

Li, X., & Heyer, W. (2008) · Cell Research · doi:10.1038/cr.2008.1 · Cited by 1,203 · see citing works

Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers

Sakai, W., Swisher, E. M., Karlan, B. Y., Agarwal, M. K., Higgins, J., Friedman, C., Villegas, E., Jacquemont, C., Farrugia, D. J., Couch, F. J., et al. (2008) · Nature · doi:10.1038/nature06633 · Cited by 1,086 · see citing works

Resistance to therapy caused by intragenic deletion in BRCA2

Edwards, S. L., Brough, R., Lord, C. J., Natrajan, R., Vatcheva, R., Levine, D. A., Boyd, J., Reis-Filho, J. S., & Ashworth, A. (2008) · Nature · doi:10.1038/nature06548 · Cited by 1,011 · see citing works

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

Rahman, N., Seal, S., Thompson, D. J., Kelly, P. F., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., Chagtai, T., et al. (2006) · Nature Genetics · doi:10.1038/ng1959 · Cited by 1,002 · see citing works

Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis

Moynahan, M. E., & Jasin, M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2851 · Cited by 923 · see citing works

Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins

Prakash, R., Zhang, Y., Feng, W., & Jasin, M. (2015) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016600 · Cited by 869 · see citing works

Maintaining genome stability at the replication fork

Branzei, D., & Foiani, M. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2852 · Cited by 786 · see citing works

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

Meindl, A., Hellebrand, H., Wiek, C., Erven, V., Wappenschmidt, B., Niederacher, D., Freund, M., Lichtner, P., Hartmann, L., Schaal, H., et al. (2010) · Nature Genetics · doi:10.1038/ng.569 · Cited by 743 · see citing works

Identification of the FANCI Protein, a Monoubiquitinated FANCD2 Paralog Required for DNA Repair

Smogorzewska, A., Matsuoka, S., Vinciguerra, P., McDonald, E. R., Hurov, K. E., Luo, J., Ballif, B. A., Gygi, S. P., Hofmann, K., D’Andrea, A. D., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.009 · Cited by 695 · see citing works

Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins

Wang, W. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2159 · Cited by 663 · see citing works

The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance

Bouwman, P., & Jonkers, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3342 · Cited by 615 · see citing works

PALB2 is an integral component of the BRCA complex required for homologous recombination repair

Sy, S. M.-H., Huen, M. S. Y., & Chen, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811159106 · Cited by 607 · see citing works

Fanconi anaemia and the repair of Watson and Crick DNA crosslinks

Kottemann, M. C., & Smogorzewska, A. (2013) · Nature · doi:10.1038/nature11863 · Cited by 608 · see citing works

How the Fanconi Anemia Pathway Guards the Genome

Moldovan, G., & D’Andrea, A. D. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102108-134222 · Cited by 586 · see citing works

PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response

Zhang, F., Ma, J., Wu, J., Ye, L., Cai, H., Xia, B., & Yu, X. (2009) · Current Biology · doi:10.1016/j.cub.2009.02.018 · Cited by 556 · see citing works

BRCA1 and its toolbox for the maintenance of genome integrity

Huen, M. S. Y., Sy, S. M.-H., & Chen, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2831 · Cited by 495 · see citing works

The emerging landscape of breast cancer susceptibility

Stratton, M. R., & Rahman, N. (2008) · Nature Genetics · doi:10.1038/ng.2007.53 · Cited by 487 · see citing works

Ten Genes for Inherited Breast Cancer

Walsh, T., & King, M.-C. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.010 · Cited by 477 · see citing works

A recurrent mutation in PALB2 in Finnish cancer families

Erkko, H., Xia, B., Nikkilä, J., Schleutker, J., Syrjäkoski, K., Mannermaa, A., Kallioniemi, A. H., Pylkäs, K., Karppinen, S., Rapakko, K., et al. (2007) · Nature · doi:10.1038/nature05609 · Cited by 466 · see citing works

Susceptibility Pathways in Fanconi's Anemia and Breast Cancer

D’Andrea, A. D. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0809889 · Cited by 380 · see citing works

Mutations of the SLX4 gene in Fanconi anemia

Kim, Y., Lach, F. P., Desetty, R. D., Hanenberg, H., Auerbach, A. D., & Smogorzewska, A. (2011) · Nature Genetics · doi:10.1038/ng.750 · Cited by 372 · see citing works

Recognition, signaling, and repair of DNA double-strand breaks produced by ionizing radiation in mammalian cells: the molecular choreography

Thompson, L. H. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.06.002 · Cited by 357 · see citing works

WD40 repeat domain proteins: a novel target class?

Schapira, M., Tyers, M., Torrent, M., & Arrowsmith, C. H. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.179 · Cited by 335 · see citing works

Expanded roles of the Fanconi anemia pathway in preserving genomic stabilityPreprint

Kee, Y., & D’Andrea, A. D. (2010) · Genes & Development · doi:10.1101/gad.1955310 · Cited by 309 · see citing works

Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination

Buisson, R., Dion‐Côté, A., Coulombe, Y., Launay, H., Cai, H., Stasiak, A. Z., Stasiak, A., Xia, B., & Masson, J. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1915 · Cited by 303 · see citing works

PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2

Zhang, F., Fan, Q., Ren, K., & Andreassen, P. R. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0123 · Cited by 303 · see citing works

Genetic Predisposition to Breast Cancer: Past, Present, and Future

Turnbull, C., & Rahman, N. (2008) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.9.081307.164339 · Cited by 301 · see citing works

BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study

Zhen, D. B., Rabe, K. G., Gallinger, S., Syngal, S., Schwartz, A. G., Goggins, M. G., Hruban, R. H., Cote, M. L., McWilliams, R. R., Roberts, N. J., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.153 · Cited by 295 · see citing works

Molecular pathogenesis and clinical management of Fanconi anemia

Kee, Y., & D’Andrea, A. D. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58321 · Cited by 284 · see citing works

Biallelic Mutations in BRCA1 Cause a New Fanconi Anemia Subtype

Sawyer, S. L., Tian, L., Kähkönen, M., Schwartzentruber, J., Kircher, M., Majewski, J., Dyment, D. A., Innes, A. M., Boycott, K. M., Moreau, L. A., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1156 · Cited by 282 · see citing works

PALB2 mutations in European familial pancreatic cancer families

Slater, E., Langer, P., Niemczyk, E., Strauch, K., Butler, J., Habbe, N., Neoptolemos, J., Greenhalf, W., & Bartsch, D. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01425.x · Cited by 278 · see citing works

Structural and Functional Relationships of the XPF/MUS81 Family of Proteins

Ciccia, A., McDonald, N. Q., & West, S. C. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.070306.102408 · Cited by 278 · see citing works

FANCI is a second monoubiquitinated member of the Fanconi anemia pathway

Sims, A. E., Spiteri, E., Sims, R. J., Arita, A., Lach, F. P., Landers, T., Wurm, M., Freund, M., Neveling, K., Hanenberg, H., et al. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1252 · Cited by 275 · see citing works

A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink Repair Independent of Homologous Recombination

Wang, A. T., Kim, T., Wagner, J. E., Conti, B. A., Lach, F. P., Huang, A. L., Molina, H., Sanborn, E. M., Zierhut, H. A., Cornes, B. K., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.009 · Cited by 269 · see citing works

Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response

Reinhardt, H. C., & Yaffe, M. B. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3640 · Cited by 260 · see citing works

Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer

Casadei, S., Norquist, B. M., Walsh, T., Stray, S. M., Mandell, J. B., Lee, M. K., Stamatoyannopoulos, J. A., & King, M. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3958 · Cited by 242 · see citing works

FANCM and FAAP24 Function in ATR-Mediated Checkpoint Signaling Independently of the Fanconi Anemia Core Complex

Collis, S. J., Ciccia, A., Deans, A. J., Hořejšı́, Z., Martin, J. S., Maslen, S., Skehel, M. J., Elledge, S. J., West, S. C., & Boulton, S. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.10.014 · Cited by 210 · see citing works

Analysis of PALB2 / FANCN -associated breast cancer families

Tischkowitz, M. D., Xia, B., Sabbaghian, N., Reis-Filho, J. S., Hamel, N., Li, G., van Beers, E. H., Li, L., Khalil, T., Quenneville, L., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701724104 · Cited by 211 · see citing works

DNA Damage and Repair: From Molecular Mechanisms to Health Implications

Fabio Altieri, F., Grillo, C., Maceroni, M., & Chichiarelli, S. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2007.1830 · Cited by 212 · see citing works

The genetic and molecular basis of Fanconi anemia

de Winter, J. P., & Joenje, H. (2008) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2008.11.004 · Cited by 206 · see citing works

Interplay between Fanconi anemia and homologous recombination pathways in genome integrity

Michl, J., Zimmer, J., & Tarsounas, M. (2016) · The EMBO Journal · doi:10.15252/embj.201693860 · Cited by 204 · see citing works

PALB2/FANCN: Recombining Cancer and Fanconi Anemia

Tischkowitz, M. D., & Xia, B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1012 · Cited by 196 · see citing works

The therapeutic significance of mutational signatures from DNA repair deficiency in cancer

Ma, J., Setton, J. S., Lee, N. Y., Riaz, N., & Powell, S. N. (2018) · Nature Communications · doi:10.1038/s41467-018-05228-y · Cited by 192 · see citing works

BOD1L Is Required to Suppress Deleterious Resection of Stressed Replication Forks

Higgs, M. R., Reynolds, J. J., Winczura, A., Blackford, A. N., Borel, V., Miller, E. S., Zlatanou, A., Nieminuszczy, J., Ryan, E. L., Davies, N. J., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.007 · Cited by 194 · see citing works

Cell cycle–dependent chromatin loading of the Fanconi anemia core complex by FANCM/FAAP24

Kim, J. M., Kee, Y., Gurtan, A. M., & D’Andrea, A. D. (2008) · Blood · doi:10.1182/blood-2007-09-113092 · Cited by 189 · see citing works

PALB2 Interacts with KEAP1 To Promote NRF2 Nuclear Accumulation and Function

Ma, J., Cai, H., Wu, T., Sobhian, B., Huo, Y., Alcivar, A. L., Mehta, M., Cheung, K. L., Ganesan, S., Kong, A. T., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06271-11 · Cited by 193 · see citing works

Analysis of the Gene Coding for the BRCA2-Interacting Protein PALB2 in Familial and Sporadic Pancreatic Cancer

Tischkowitz, M. D., Sabbaghian, N., Hamel, N., Borgida, A., Rosner, C., Taherian, N., Srivastava, A., Holter, S., Rothenmund, H., Ghadirian, P., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.055 · Cited by 187 · see citing works

Coupling of Homologous Recombination and the Checkpoint by ATR

Buisson, R., Joshi, N., Rodrigue, A., Ho, C. K., Kreuzer, J., Foo, T. K., Hardy, É. J.-L., Dellaire, G., Haas, W., Xia, B., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2016.12.007 · Cited by 181 · see citing works

Structural basis for recruitment of BRCA2 by PALB2

Oliver, A. W., Swift, S., Lord, C. J., Ashworth, A., & Pearl, L. H. (2009) · EMBO Reports · doi:10.1038/embor.2009.126 · Cited by 181 · see citing works

Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2

Dray, E. V., Etchin, J., Wiese, C., Saro, D., Williams, G. J., Hammel, M., Yu, X., Galkin, V. E., Liu, D., Tsai, M.-S., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1916 · Cited by 168 · see citing works

A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51

Ameziane, N., May, P., Haitjema, A., van de Vrugt, H. J., van Rossum-Fikkert, S. E., Ristić, D., Williams, G. J., Balk, J. A., Rockx, D., Li, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms9829 · Cited by 165 · see citing works

FAAP100 is essential for activation of the Fanconi anemia‐associated DNA damage response pathway

Ling, C., Ishiai, M., Ali, A. M., Medhurst, A. L., Neveling, K., Kalb, R., Yan, Z., Xue, Y., Oostra, A. B., Auerbach, A. D., et al. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601666 · Cited by 167 · see citing works

Identification of a novel truncating PALB2mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women

Foulkes, W. D., Ghadirian, P., Akbari, M. R., Hamel, N., Giroux, S., Sabbaghian, N., Darnel, A. D., Royer, R., Poll, A., Fafard, E., et al. (2007) · Breast Cancer Research · doi:10.1186/bcr1828 · Cited by 156 · see citing works

Rad51 Paralogs Remodel Pre-synaptic Rad51 Filaments to Stimulate Homologous Recombination

Taylor, M. R. G., Špı́rek, M., Chaurasiya, K. R., Ward, J. D., Carzaniga, R., Yu, X., Egelman, E. H., Collinson, L., Rueda, D., Krejčí, L., et al. (2015) · Cell · doi:10.1016/j.cell.2015.06.015 · Cited by 154 · see citing works

The role of DNA damage repair in aging of adult stem cells

Kenyon, J. D., & Gerson, S. L. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm1064 · Cited by 152 · see citing works

Fancm-deficient mice reveal unique features of Fanconi anemia complementation group M

Bakker, S. T., van de Vrugt, H. J., Rooimans, M. A., Oostra, A. B., Steltenpool, J., Delzenne‐Goette, E., van der Wal, A., van der Valk, M., Joenje, H., Riele, H. T., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp297 · Cited by 148 · see citing works

Biallelic Deleterious BRCA1 Mutations in a Woman with Early-Onset Ovarian Cancer

Domchek, S. M., Tang, J.-B., Stopfer, J. E., Lilli, D. R., Hamel, N., Tischkowitz, M. D., Monteiro, Á. N. A., Messick, T. E., Powers, J., Yonker, A., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0421 · Cited by 146 · see citing works

Genotype–phenotype correlations in Fanconi anemia

Neveling, K., Endt, D., Hoehn, H., & Schindler, D. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.05.006 · Cited by 144 · see citing works

Deficiency of UBE2T, the E2 Ubiquitin Ligase Necessary for FANCD2 and FANCI Ubiquitination, Causes FA-T Subtype of Fanconi Anemia

Rickman, K. A., Lach, F. P., Abhyankar, A., Donovan, F. X., Sanborn, E. M., Kennedy, J. A., Sougnez, C. L., Gabriel, S., Elemento, O., Chandrasekharappa, S. C., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.014 · Cited by 141 · see citing works

Diseases Associated with Defective Responses to DNA DamagePreprint

O’Driscoll, M. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012773 · Cited by 139 · see citing works

Hypomorphic Mutations in the Gene Encoding a Key Fanconi Anemia Protein, FANCD2, Sustain a Significant Group of FA-D2 Patients with Severe Phenotype

Kalb, R., Neveling, K., Hoehn, H., Schneider, H., Linka, Y., Batish, S. D., Hunt, C., Berwick, M., Callén, E., Surrallés, J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/517616 · Cited by 139 · see citing works

Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair

Park, J.-Y., Singh, T. R., Nassar, N., Zhang, F., Freund, M., Hanenberg, H., Meetei, A. R., & Andreassen, P. R. (2014) · Oncogene · doi:10.1038/onc.2013.421 · Cited by 130 · see citing works

RAD51C is a susceptibility gene for ovarian cancer

Pelttari, L. M., Heikkinen, T., Thompson, D. J., Kallioniemi, A. H., Schleutker, J., Holli, K., BLOMQVIST, C. P., Aittomäki, K., Bützow, R. C., & Nevanlinna, H. A. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr229 · Cited by 136 · see citing works

The Breast Cancer Susceptibility Mutation PALB2 1592delT Is Associated with an Aggressive Tumor Phenotype

Heikkinen, T., Kärkkäinen, H., Aaltonen, K., Milne, R. L., Heikkilä, P., Aittomäki, K., BLOMQVIST, C. P., & Nevanlinna, H. A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3128 · Cited by 138 · see citing works

Impaired FANCD2 monoubiquitination and hypersensitivity to camptothecin uniquely characterize Fanconi anemia complementation group M

Singh, T. R., Bakker, S. T., Agarwal, S., Jansen, M., Grassman, E., Godthelp, B. C., Ali, A. M., Du, C.-H., Rooimans, M. A., Fan, Q., et al. (2009) · Blood · doi:10.1182/blood-2009-02-207811 · Cited by 135 · see citing works

TNF-α induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells

Li, J., Sejas, D. P., Zhang, X., Qiu, Y., Nattamai, K., Rani, R., Rathbun, K. R., Geiger, H., Williams, D. A., Bagby, G. C., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31772 · Cited by 134 · see citing works

Autophagy Opposes p53-Mediated Tumor Barrier to Facilitate Tumorigenesis in a Model of PALB2 -Associated Hereditary Breast Cancer

Huo, Y., Cai, H., Teplova, I., Bowman-Colin, C., Chen, G., Price, S. M., Barnard, N., Ganesan, S., Karantza, V., White, E., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0011 · Cited by 132 · see citing works

Somatic genetic rescue in Mendelian haematopoietic diseases

Revy, P., Kannengiesser, C., & Fischer, A. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0139-x · Cited by 130 · see citing works

Oxidative Stress in Fanconi Anemia Hematopoiesis and Disease Progression

Du, W., Ádám, Z., Rani, R., Zhang, X., & Pang, Q. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2129 · Cited by 129 · see citing works

Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States

Ding, Y. C., Steele, L., Kuan, C.-J., Greilac, S., & Neuhausen, S. L. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1195-2 · Cited by 125 · see citing works

Counting potentially functional variants in BRCA1, BRCA2 and ATM predicts breast cancer susceptibility

Johnson, N., Fletcher, O., Palles, C., Rudd, M. F., Webb, E. L., Sellick, G. S., dos‐Santos‐Silva, I., McCormack, V., Gibson, L., Fraser, A., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm050 · Cited by 124 · see citing works

Identification of the Fanconi Anemia Complementation Group I Gene, FANCI

Dorsman, J. C., Levitus, M., Rockx, D., Rooimans, M. A., Oostra, A. B., Haitjema, A., Bakker, S. T., Steltenpool, J., Schuler, D., Mohan, S., et al. (2007) · Analytical Cellular Pathology · doi:10.1155/2007/151968 · Cited by 133 · see citing works

Novel insights into RAD51 activity and regulation during homologous recombination and DNA replication

Godin, S. K., Sullivan, M. R., & Bernstein, K. A. (2016) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0012 · Cited by 121 · see citing works

FANCM of the Fanconi anemia core complex is required for both monoubiquitination and DNA repair

Xue, Y., Li, Y., Guo, R., Ling, C., & Wang, W. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn054 · Cited by 121 · see citing works

RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer

Somyajit, K., Subramanya, S., & Nagaraju, G. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq210 · Cited by 119 · see citing works

Recent advances of therapeutic targets based on the molecular signature in breast cancer: genetic mutations and implications for current treatment paradigms

Lima, Z. S., Ghadamzadeh, M., Arashloo, F. T., Amjad, G., Ebadi, M. R., & Younesi, L. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0725-6 · Cited by 118 · see citing works

A novel germline PALB2 deletion in Polish breast and ovarian cancer patients

Dansonka‐Mieszkowska, A., Kluska, A., Moes-Sosnowska, J., Dąbrowska, M., Nowakowska, D., Niwińska, A., Derlatka, P., Cendrowski, K., & Kupryjańczyk, J. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-20 · Cited by 118 · see citing works

Links between genome integrity and BRCA1 tumor suppression

Covington, M. L., & Greenberg, R. A. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.06.007 · Cited by 116 · see citing works

Phosphorylated RPA recruits PALB2 to stalled DNA replication forks to facilitate fork recovery

Murphy, A., Fitzgerald, M., Ro, T., Kim, J. H., Rabinowitsch, A. I., Chowdhury, D., Schildkraut, C. L., & Borowiec, J. A. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201404111 · Cited by 112 · see citing works

The Fanconi anaemia pathway orchestrates incisions at sites of crosslinked DNA

Crossan, G. P., & Patel, K. J. (2011) · The Journal of Pathology · doi:10.1002/path.3002 · Cited by 111 · see citing works

BRCA2 is required for neurogenesis and suppression of medulloblastoma

Frappart, P., Lee, Y., Lamont, J. M., & McKinnon, P. J. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601703 · Cited by 110 · see citing works

Hereditary Breast Cancer and the BRCA1-Associated FANCJ/BACH1/BRIP1

Cantor, S. B., & Guillemette, S. (2011) · Future Oncology · doi:10.2217/fon.10.191 · Cited by 106 · see citing works

Binding of FANCI-FANCD2 Complex to RNA and R-Loops Stimulates Robust FANCD2 Monoubiquitination

Liang, Z., Liang, F., Teng, Y., Chen, X., Liu, J., Longerich, S., Rao, T., Green, A. M., Collins, N. B., Xiong, Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2018.12.084 · Cited by 104 · see citing works

The Role of PALB2 in the DNA Damage Response and Cancer Predisposition

Nepomuceno, T. C., Gregoriis, G. D., de Oliveira, F. M. B., Suarez‐Kurtz, G., Monteiro, Á. N. A., & Carvalho, M. A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091886 · Cited by 108 · see citing works

Minding the gap: The underground functions of BRCA1 and BRCA2 at stalled replication forks

Nagaraju, G., & Scully, R. (2007) · DNA repair · doi:10.1016/j.dnarep.2007.02.020 · Cited by 103 · see citing works

6-Thioguanine Selectively Kills BRCA2-Defective Tumors and Overcomes PARP Inhibitor Resistance

Issaeva, N., Thomas, H. D., Djurenovic, T., Jaspers, J. E., Stoimenov, I., Kyle, S., Pedley, N., Gottipati, P., Zur, R., Sleeth, K. M., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3416 · Cited by 104 · see citing works

Penetrance Analysis of the PALB2 c.1592delT Founder Mutation

Erkko, H., Dowty, J. G., Nikkilä, J., Syrjäkoski, K., Mannermaa, A., Pylkäs, K., Southey, M. C., Holli, K., Kallioniemi, A. H., Jukkola‐Vuorinen, A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0210 · Cited by 102 · see citing works

The Tumor Suppressor PALB2: Inside Out

Ducy, M., Sesma-Sanz, L., Guitton-Sert, L., Lashgari, A., Gao, Y., Brahiti, N., Rodrigue, A., Margaillan, G., Caron, M., Côté, J., et al. (2019) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.10.008 · Cited by 101 · see citing works

Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families

García, M. J., Fernández, V., Osório, A., Barroso, A., Llort, G., Lázaro, C., Blanco, I., Caldés, T., de la Hoya, M., y Cajal, T. R., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9945-0 · Cited by 102 · see citing works

PALB2 Regulates Recombinational Repair through Chromatin Association and Oligomerization

Sy, S. M.-H., Huen, M. S. Y., Zhu, Y., & Chen, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016717 · Cited by 98 · see citing works

BRIP1, PALB2, and RAD51C mutation analysis reveals their relative importance as genetic susceptibility factors for breast cancer

Wong‐Brown, M. W., Nordfors, C., Mossman, D., Pecenpetelovska, G., Avery‐Kiejda, K. A., Talseth‐Palmer, B. A., Bowden, N. A., & Scott, R. J. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1443-0 · Cited by 100 · see citing works

BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance

Nacson, J., Krais, J. J., Bernhardy, A. J., Clausen, E., Feng, W., Wang, Y., Nicolas, É., Cai, K. Q., Tricarico, R., Hua, X., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.08.086 · Cited by 98 · see citing works

Promoter Hypermethylation of the PALB2 Susceptibility Gene in Inherited and Sporadic Breast and Ovarian Cancer

Potapova, A., Hoffman, A. M., Godwin, A. K., Al‐Saleem, T., & Cairns, P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2418 · Cited by 96 · see citing works

Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players

Rahman, N., & Scott, R. H. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm026 · Cited by 94 · see citing works

Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management

Wu, S., Zhou, J., Zhang, K., Chen, H., Luo, M., Lu, Y., Sun, Y., & Chen, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00301 · Cited by 93 · see citing works

A Novel Breast Cancer–Associated <i>BRIP1</i> ( <i>FANCJ/BACH1</i> ) Germ-line Mutation Impairs Protein Stability and Function

De Nicolo, A., Tancredi, M., Lombardi, G., Flemma, C. C., Barbuti, S., Di Cristofano, C., Sobhian, B., Bevilacqua, G., Drapkin, R., & Caligo, M. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0087 · Cited by 91 · see citing works

Fanconi Anemia

Green, A. M., & Kupfer, G. M. (2009) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2009.01.008 · Cited by 89 · see citing works

FANCG promotes formation of a newly identified protein complex containing BRCA2, FANCD2 and XRCC3

Wilson, J. B., Yamamoto, K., Marriott, A. S., Hussain, S., Sung, P., Hoatlin, M. E., Mathew, C. G., Takata, M., Thompson, L., Kupfer, G. M., et al. (2008) · Oncogene · doi:10.1038/sj.onc.1211034 · Cited by 91 · see citing works

Targeting the DNA damage response for cancer therapy

Powell, S. N., & Bindra, R. S. (2009) · DNA repair · doi:10.1016/j.dnarep.2009.04.011 · Cited by 86 · see citing works

Interconnected

Seton-Rogers, S. E. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2078

PALB2/FANCN: Recombining Cancer and Fanconi Anemia

Tischkowitz, M. D., & Xia, B. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1012 · Cited by 196 · see citing works

Cross-links between Fanconi anaemia and BRCA2

West, S. C. (2003) · DNA repair · doi:10.1016/s1568-7864(02)00168-4 · Cited by 7 · see citing works

PALB2 (partner and localizer of BRCA2)

Hanenberg, H., & Andreassen, P. R. (2018) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/69016 · Cited by 70 · see citing works

Fanconi anemia and breast cancer susceptibility

Patel, K. J. (2007) · Nature Genetics · doi:10.1038/ng0207-142 · Cited by 29 · see citing works